Reuning U, Magdolen V, Wilhelm O, Fischer K, Lutz V, Graeff H, Schmitt M
Frauenklinik der Technischen Universitat Munchen, Klinikum rechts der Isar, D-81675 Munchen, Germany.
Int J Oncol. 1998 Nov;13(5):893-906. doi: 10.3892/ijo.13.5.893.
Tumor cell migration and invasion into the surrounding tissue depend on the invasive capacity of cells leading to the loosening of cell-cell and cell-substratum contacts via cell surface associated proteolytic enzyme systems. Plasmin is one of the enzymes involved in these complex events. It is generated by the cleavage of the proenzyme plasminogen upon the action of the urokinase-type plasminogen activator (uPA). uPA is synthesized and secreted by tumor cells and normal cells and interacts with a specific cell surface receptor (uPAR) thereby focalizing enzymatic activity to the cell surface. The activity of uPA is controlled by plasminogen activator inhibitors type-1 and type-2. A strong statistically independent prognostic impact has been attributed to uPA and its inhibitor PAI-1 in a variety of malignancies. Besides its proteolytic activity, uPA in concert with uPAR exert biological effects characteristic for molecules with signal transducing properties including chemotaxis, migration/invasion, adhesion, and mitogenesis.
肿瘤细胞向周围组织的迁移和侵袭取决于细胞的侵袭能力,这会通过细胞表面相关的蛋白水解酶系统导致细胞间和细胞与基质接触的松动。纤溶酶是参与这些复杂事件的酶之一。它是在尿激酶型纤溶酶原激活剂(uPA)的作用下,由酶原纤溶酶原裂解产生的。uPA由肿瘤细胞和正常细胞合成并分泌,并与特定的细胞表面受体(uPAR)相互作用,从而将酶活性集中在细胞表面。uPA的活性受1型和2型纤溶酶原激活剂抑制剂的控制。在多种恶性肿瘤中,uPA及其抑制剂PAI-1具有强大的统计学独立预后影响。除了其蛋白水解活性外,uPA与uPAR协同发挥具有信号转导特性的分子的生物学效应,包括趋化性、迁移/侵袭、粘附和有丝分裂。